Document:

Exhibit
10.6

 

 

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT

 

THIS PRIVATE PLACEMENT WARRANTS
PURCHASE AGREEMENT, dated as of [______], 2020 (as it may from time to time be amended, this “Agreement”), is
entered into by and between Bridgetown Holdings Limited, a Cayman Islands exempted company (the “Company”),
and Bridgetown LLC, a Cayman Islands limited liability company (the “Purchaser”).

 

WHEREAS:

 

The Company intends to consummate
an initial public offering of the Company’s units (the “Public Offering”), each unit consisting of one
Class A ordinary share of the Company, of par value $0.0001 per share (each, a “Share”), and one-half of
one redeemable warrant;

 

Each whole warrant entitles
the holder to purchase one Share at an exercise price of $11.50 per Share; and

 

The Purchaser has agreed
to purchase, at a price of $1.00 per warrant, an aggregate of 9,000,000 warrants (or up to 10,125,000 warrants if the over-allotment
option in connection with the Public Offering is exercised in full) (the “Private Placement Warrants”), each
Private Placement Warrant entitling the holder to purchase one Share at an exercise price of $11.50 per Share; and

 

The underwriters in the Public
Offering will not receive up-front underwriting discounts or commissions on up to the higher of (a) $50 million and (b) 35%
of the total Public Offering size that may be purchased by (x) the Purchaser or its affiliates (including FWD), and (y) certain
investors identified by the Company, in the Public Offering (such Public Offering purchasers, the “Affiliated Purchasers”),
if any.

 

NOW THEREFORE, in consideration
of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1.  Authorization, Purchase and Sale; Terms
of the Private Placement Warrants.

 

A.  Authorization
of the Private Placement Warrants.  The Company has duly authorized the issuance and sale of the Private Placement Warrants
to the Purchaser.

 

B.  Purchase and Sale
of the Private Placement Warrants.

 

(i)  Simultaneously
with the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the Purchaser and the
Company (the “Initial Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall
purchase from the Company, an aggregate of 9,000,000 Private Placement Warrants at a price of $1.00 per warrant for an aggregate
purchase price of $9,000,000 (the “Purchase Price”). Purchaser shall pay the Purchase Price by wire transfer
of immediately available funds to the trust account (the “Trust Account”) maintained by Continental Stock Transfer
& Trust Company, acting as trustee (“Continental”), at least one (1) business day prior to the date of effectiveness
(the “Effective Date”) of the registration statement relating to the Public Offering (the “Registration
Statement”).  On the Initial Closing Date, upon the payment by the Purchaser of the Purchase Price, the Company,
at its option, shall deliver a certificate evidencing the Private Placement Warrants purchased on such date duly registered in
the Purchaser’s name to the Purchaser or effect such delivery in book-entry form.

        

(ii)  Simultaneously
with the consummation of the closing of the over-allotment option in connection with the Public Offering (the “Over-Allotment
Option”) or on such earlier time and date as may be mutually agreed by the Purchaser and the Company (each such date,
an “Over-allotment Closing Date,” and each Over-allotment Closing Date (if any) and the Initial Closing Date
being sometimes referred to herein as a “Closing Date”), the Company shall issue and sell to the Purchaser,
and the Purchaser shall purchase from the Company, an aggregate of up to 1,125,000 Private Placement Warrants at a price of $1.00
per warrant for an aggregate purchase price of up to $1,125,000 (if the over-allotment option in connection with the Public Offering
is exercised in full) (the “Over-allotment Purchase Price”). Purchaser shall pay the Over-allotment Purchase
Price by wire transfer of immediately available funds to the Trust Account maintained by Continental at least one (1) business
day prior to the Over-allotment Closing Date.  On the Over-allotment Closing Date, upon the payment by the Purchaser of the
Over-allotment Purchase Price to the Company, the Company shall, at its option, deliver a certificate evidencing the Private Placement
Warrants purchased on such date duly registered in the Purchaser’s name to the Purchaser or effect such delivery in book-entry
form. 

 

    

     

    

 

(iii)       Notwithstanding
the foregoing, in the event that Affiliated Purchasers purchase units in the Public Offering, the number of Private Placement Warrants
to be purchased by the Purchaser shall be reduced pro rata to account for the corresponding reduction in up-front underwriting
discounts or commissions payable by the Company upon completion of the Public Offering.

C.  Terms of the Private
Placement Warrants.

 

(i)  Each Private
Placement Warrant shall have the terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent,
in connection with the Public Offering (the “Warrant Agreement”).

 

(ii)  On the Effective
Date, the Company and the Purchaser shall enter into a registration rights agreement (the “Registration Rights Agreement”)
pursuant to which the Company will grant certain registration rights to the Purchaser relating to the Private Placement Warrants
and the Shares underlying the Private Placement Warrants.

 

(iii) The Private Placement
Warrants shall be terminated upon the dissolution of the Company or in the event that the Company does not consummate an initial
business combination within the time period set forth in the Company’s memorandum and articles of association, as the same
may be amended from time to time.

 

Section 2.  Representations and
Warranties of the Company.  As a material inducement to the Purchaser to enter into this Agreement and purchase the Private
Placement Warrants, the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive
each Closing Date) that:

 

A.  Incorporation
and Corporate Power.  The Company is an exempted company duly incorporated, validly existing and in good standing under
the laws of the Cayman Islands and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably
be expected to have a material adverse effect on the financial condition, operating results or assets of the Company.  The
Company possesses all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement
and the Warrant Agreement.

 

B.  Authorization; No
Breach.

 

(i)  The execution,
delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized by the Company as of the
Closing Date.  This Agreement constitutes the valid and binding obligation of the Company, enforceable in accordance with
its terms.  Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement,
the Private Placement Warrants will constitute valid and binding obligations of the Company, enforceable in accordance with their
terms as of the Closing Dates.

 

(ii)  The execution
and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement
Warrants, the issuance of the Shares upon exercise of the Private Placement Warrants and the fulfillment, of and compliance with,
the respective terms hereof and thereof by the Company, do not and will not as of the Closing Dates (a) conflict with or result
in a breach of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of
any lien, security interest, charge or encumbrance upon the Company’s share capital or assets under, (d) result in a
violation of, or (e) require any authorization, consent, approval, exemption or other action by or notice or declaration to,
or filing with, any court or administrative or governmental body or agency pursuant to the memorandum and articles of association
of the Company (in effect on the date hereof or as may be amended prior to completion of the contemplated Public Offering), or
any material law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment or decree
to which the Company is subject, except for any filings required after the date hereof under federal or state securities laws.

  

C.  Title
to Securities.  Upon issuance in accordance with, and payment pursuant to, and registration in the register of members
of the Company, the terms hereof, the Warrant Agreement and the memorandum and articles of association of the Company, the Shares
issuable upon exercise of the Private Placement Warrants will be duly and validly issued as fully paid and nonassessable. On the
date of issuance of the Private Placement Warrants, the Shares issuable upon exercise of the Private Placement Warrants shall have
been reserved for issuance. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement,
the Purchaser will have good title to the Private Placement Warrants and the Shares issuable upon exercise of such Private Placement
Warrants, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder
and under the other agreements contemplated hereby, (ii) transfer restrictions under federal and state securities laws, and
(iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

 

    2

     

    

   

D.  Governmental
Consents.  No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority
is required in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by
the Company of any other transactions contemplated hereby.

 

E. Regulation
D Qualification. Neither the Company nor, to its actual knowledge, any of its officers, directors or beneficial shareholders
of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation
D under the Securities Act of 1933, as amended (the “Securities Act”).

 

Section 3.  Representations and
Warranties of the Purchaser.  As a material inducement to the Company to enter into this Agreement and issue and sell
the Private Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations
and warranties shall survive each Closing Date) that:

 

A.  Organization
and Requisite Authority.  The Purchaser possesses all requisite power and authority necessary to carry out the transactions
contemplated by this Agreement.

 

B.  Authorization; No
Breach.

 

(i) This Agreement constitutes
a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights
and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii) The execution and
delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does not
and shall not as of each Closing Date conflict with or result in a breach by the Purchaser of the terms, conditions or provisions
of any agreement, instrument, order, judgment or decree to which the Purchaser is subject.

  

C.  Investment Representations.

 

(i) The Purchaser is acquiring
the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable upon such exercise (collectively,
the “Securities”), for the Purchaser’s own account, for investment purposes only and not with a view towards,
or for resale in connection with, any public sale or distribution thereof.

 

(ii) The Purchaser is an
“accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act
and the Purchaser has not experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities
Act.

        

(iii) The Purchaser understands
that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration requirements
of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the
Purchaser’s compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv) The Purchaser decided
to enter into this Agreement not as a result of any general solicitation or general advertising within the meaning of Rule 502(c) under
the Securities Act.

 

    3

     

    

  

(v) The Purchaser has been
furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer
and sale of the Securities which have been requested by the Purchaser.  The Purchaser has been afforded the opportunity to
ask questions of the executive officers and directors of the Company.  The Purchaser understands that its investment in the
Securities involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary
to make an informed investment decision with respect to the acquisition of the Securities.

 

(vi) The Purchaser understands
that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation
or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser nor have such
authorities passed upon or endorsed the merits of the offering of the Securities.

 

(vii) The Purchaser understands
that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities laws,
and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold
in reliance on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither
the Company nor any other person is under any obligation to register the Securities under the Securities Act or any state securities
laws or to comply with the terms and conditions of any exemption thereunder.  The Private Placement Warrants will bear a legend
and appropriate “stop transfer” instructions (or an appropriate notation if the warrants are issued in book entry form)
relating to the foregoing. The Purchaser further understands that the Securities and Exchange Commission (the “SEC”)
has taken the position that promoters or affiliates of a blank check company and their transferees, both before and after an initial
business combination, are deemed to be “underwriters” under the Securities Act when reselling the securities of a blank
check company.  Based on that position, Rule 144 adopted pursuant to the Securities Act would not be available for resale
transactions of the Securities until the one-year anniversary following consummation of an initial business combination despite
technical compliance with the requirements of such Rule.

 

(viii) The Purchaser has
such knowledge and experience in financial and business matters, knows of the high degree of risk associated with investments in
the securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment
in the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder
for an indefinite period of time.  The Purchaser has adequate means of providing for its current financial needs and contingencies
and will have no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities. 
The Purchaser can afford a complete loss of its investment in the Securities.

 

Section 4.  Conditions of the
Purchaser’s Obligations.  The obligations of the Purchaser to purchase and pay for the Private Placement Warrants
are subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

A. Representations
and Warranties.  The representations and warranties of the Company contained in Section 2 shall be true and correct
at and as of such Closing Date as though then made.

 

B. Performance. 
The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that
are required to be performed or complied with by it on or before such Closing Date.

 

C. No
Injunction.  No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory
organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
contemplated by this Agreement or the Warrant Agreement.

 

    4

     

    

 

 

D. Warrant
Agreement and Registration Rights Agreement.  The Company shall have entered into the Warrant Agreement with a warrant
agent and a registration rights agreement, in each case on terms satisfactory to the Purchaser. 

 

E. Corporate
Consents. The Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance
of this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants.

 

Section 5.  Conditions of the
Company’s Obligations.  The obligations of the Company to the Purchaser under this Agreement are subject to the
fulfillment, on or before each Closing Date, of each of the following conditions:

 

A.  Representations
and Warranties.  The representations and warranties of the Purchaser contained in Section 3 shall be true and correct
at and as of such Closing Date as though then made.

 

B.  Performance. 
The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that
are required to be performed or complied with by the Purchaser on or before such Closing Date.

 

C.  No
Injunction.  No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory
organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
contemplated by this Agreement or the Warrant Agreement.

 

D.  Warrant
Agreement and Registration Rights Agreement.  The Company shall have entered into the Warrant Agreement with a warrant
agent, and a registration rights agreement, in each case on terms satisfactory to the Company.

  

Section 6.  Termination. 
This Agreement may be terminated at any time after December 31, 2020 upon the election by either the Company or the Purchaser solely
as to itself upon written notice to the other parties if the closing of the Public Offering does not occur prior to such date.

 

Section 7.  Survival of Representations
and Warranties.  All of the representations and warranties contained herein shall survive each Closing Date.

 

Section 8.  Definitions. 
Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the Registration Statement.

 

    5

     

    

  

Section 9.  Miscellaneous.

 

A.  Successors
and Assigns.  Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement
by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto
whether so expressed or not.  Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign
this Agreement without the prior written consent of the other party hereto, other than assignments by the Purchaser to affiliates
thereof.

 

B.  Severability. 
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be
ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

C.  Counterparts. 
This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than
one party, but all such counterparts taken together shall constitute one and the same agreement.

 

D.  Descriptive
Headings; Interpretation.  The descriptive headings of this Agreement are inserted for convenience only and do not constitute
a substantive part of this Agreement.  The use of the word “including” in this Agreement shall be by way
of example rather than by limitation. 

 

E.  Governing
Law.  This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes
shall be construed in accordance with the internal laws of the State of New York, without regard to the conflicts of laws principles
thereof.

 

F.  Amendments. 
This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by
all parties hereto.

 

[Signature page follows]

 

    6

     

    

  

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	BRIDGETOWN HOLDINGS LIMITED
	 	 
	 	By:	 
	 	 	Name:	Daniel Wong
	 	 	Title:	Chief Executive Officer and Chief Financial Officer
	 	 
	 	PURCHASER:
	 	 
	 	BRIDGETOWN LLC
	 	 
	 	By:	 
	 	 	Name:	 
	 	 	Title:	 

  

  

[Signature page to Private Placement
Warrants Purchase Agreement]

 

    7Exhibit 10.7

 

INDEMNITY
AGREEMENT

 

THIS
INDEMNITY AGREEMENT (this “Agreement”) is made on _____, 2020.

 

Between:

 

		(1)	Bridgetown
Holdings Limited, a Cayman Islands exempted company with its registered office at PO Box 309, Ugland House, Grand Cayman KY10-1104,
Cayman Islands (the “Company”); and

 

		(2)	(“Indemnitee”).

 

Whereas:

 

		(A)	Highly
competent persons have become more reluctant to serve publicly-held companies as directors, officers or in other capacities unless
they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and
actions against them arising out of their service to and activities on behalf of such companies;

 

		(B)	The
board of directors of the Company (the “Board”) has determined that, in order to attract and retain qualified
individuals, the Company will use commercially reasonable efforts to maintain on an ongoing basis, at its sole expense, liability
insurance to protect persons serving the Company and its subsidiaries from certain liabilities.  Although the furnishing
of such insurance has been a customary and widespread practice among publicly traded companies and other business enterprises,
the Company believes that, given current market conditions and trends, such insurance may be available to it in the future only
at higher premiums and with more exclusions.  At the same time, directors, officers and other persons in service to companies
or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to, among other things,
matters that traditionally would have been brought only against the Company or business enterprise itself.  The amended and
restated memorandum and articles of association of the Company (the “Articles”) provide for the indemnification
of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant to applicable Cayman
Islands law. The Articles expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby
contemplate that contracts may be entered into between the Company and members of the Board, officers and other persons with respect
to indemnification, hold harmless, exoneration, advancement and reimbursement rights;

 

		(C)	The
uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such
persons;

 

		(D)	The
Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests
of the Company’s shareholders and that the Company should act to assure such persons that there will be increased certainty
of such protection in the future;

 

		(E)	It
is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and
to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue
to serve the Company free from undue concern that they will not be so protected against liabilities;

 

		(F)	This
Agreement is a supplement to and in furtherance of the Articles and any resolutions adopted pursuant thereto, and shall not be
deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

 

		(G)	Indemnitee
may not be willing to serve as an officer or director, advisor or in another capacity without adequate protection, and the Company
desires Indemnitee to serve in such capacity.  Indemnitee is willing to serve, continue to serve and to take on additional
service for or on behalf of the Company on the condition that he be so indemnified; and

 

    1

     

    

 

NOW,
THEREFORE, in consideration of the premises and the covenants contained herein and subject to the provisions of the letter agreement
dated as of _______, 2020 between the Company and Indemnitee pursuant to the Underwriting Agreement between the Company and the
Underwriters in connection with the Company’s initial public offering, the Company and Indemnitee do hereby covenant and
agree as follows:

 

TERMS
AND CONDITIONS

 

		1	SERVICES TO THE COMPANY

 

Indemnitee
will serve or continue to serve as an officer, director, advisor, key employee or in any other capacity of the Company, as applicable,
for so long as Indemnitee is duly elected, appointed or retained or until Indemnitee tenders his resignation or until Indemnitee
is removed. The foregoing notwithstanding, this Agreement shall continue in full force and effect after Indemnitee has ceased
to serve as a director, officer, advisor, key employee or in any other capacity of the Company, as provided in Section 17. This
Agreement, however, shall not impose any obligation on Indemnitee or the Company to continue Indemnitee’s service to the
Company beyond any period otherwise required by law or by other agreements or commitments of the parties, if any.

 

		2	DEFINITIONS

 

As
used in this Agreement:

 

		2.1	References to “agent”
    shall mean any person who is or was a director, officer or employee of the Company or a subsidiary of the Company or other
    person authorized by the Company to act for the Company, to include such person serving in such capacity as a director, officer,
    employee, advisor, fiduciary or other official of another company, corporation, partnership, limited liability company, joint
    venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the Company
    or a subsidiary of the Company.

  

		2.2	The terms “Beneficial
    Owner” and “Beneficial Ownership” shall have the meanings set forth in Rule 13d-3 promulgated
    under the Exchange Act (as defined below) as in effect on the date hereof.

  

		2.3	“Cayman Court”
    shall mean the Grand Court of the Cayman Islands.

 

		2.4	A “Change in
    Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following
    events:

 

	 	(a)	Acquisition of Shares
    by Third Party.  Other than an affiliate of Bridgetown LLC, any Person (as defined below) is or becomes the Beneficial
    Owner, directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting
    power of the Company’s then outstanding securities entitled to vote generally in the election of directors, unless (1) the
    change in the relative Beneficial Ownership of the Company’s securities by any Person results solely from a reduction
    in the aggregate number of outstanding shares entitled to vote generally in the election of directors, or (2) such acquisition
    was approved in advance by the Continuing Directors (as defined below) and such acquisition would not constitute a Change
    in Control under part (c) of this definition;

 

	 	(b)	Change in Board of
    Directors.  Individuals who, as of the date hereof, constitute the Board, and any new director whose election by
    the Board or nomination for election by the Company’s shareholders was approved by a vote of at least two thirds of
    the directors then still in office who were directors on the date hereof or whose election or nomination for election was
    previously so approved (collectively, the “Continuing Directors”), cease for any reason to constitute at
    least a majority of the members of the Board;

 

    2

     

    

 

	 	(c)	Corporate Transactions. 
    The effective date of a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination,
    involving the Company and one or more businesses (a “Business Combination”), in each case, unless, following
    such Business Combination: (1) all or substantially all of the individuals and entities who were the Beneficial Owners
    of securities entitled to vote generally in the election of directors immediately prior to such Business Combination beneficially
    own, directly or indirectly, more than 51% of the combined voting power of the then outstanding securities of the Company
    entitled to vote generally in the election of directors resulting from such Business Combination (including, without limitation,
    a companywhich as a result of such transaction owns the Company or all or substantially all of the Company’s assets
    either directly or through one or more Subsidiaries) in substantially the same proportions as their ownership immediately
    prior to such Business Combination, of the securities entitled to vote generally in the election of directors; (2) other
    than an affiliate of Bridgetown LLC, no Person (excluding any company resulting from such Business Combination) is the Beneficial
    Owner, directly or indirectly, of 15% or more of the combined voting power of the then outstanding securities entitled to
    vote generally in the election of directors of the surviving company except to the extent that such ownership existed prior
    to the Business Combination; and (3) at least a majority of the Board resulting from such Business Combination were Continuing
    Directors at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business
    Combination;

 

	 	(d)	Liquidation. 
    The approval by the shareholders of the Company of a complete liquidation of the Company or an agreement or series of agreements
    for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than factoring
    the Company’s current receivables or escrows due (or, if such approval is not required, the decision by the Board to
    proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions); or

 

	 	(e)	Other Events. 
    There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A
    of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as
    defined below), whether or not the Company is then subject to such reporting requirement.

 

		2.5	“Corporate
    Status” describes the status of a person who is or was a director, officer, trustee, general partner, manager, managing
    member, fiduciary, employee or agent of the Company or of any other Enterprise (as defined below) which such person is or
    was serving at the request of the Company.

 

		2.6	“Disinterested
    Director” shall mean a director of the Company who is not and was not a party to the Proceeding (as defined below)
    in respect of which indemnification is sought by Indemnitee.

 

		2.7	“Enterprise”
    shall mean the Company and any other company, corporation, constituent company or corporation (including any constituent of
    a constituent) absorbed in a consolidation or merger to which the Company (or any of its wholly owned subsidiaries) is a party,
    limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee
    is or was serving at the request of the Company as a director, officer, trustee, general partner, manager, managing member,
    fiduciary, employee or agent.

 

		2.8	“Exchange Act”
    shall mean the United States Securities Exchange Act of 1934, as amended.

 

		2.9	“Expenses”
    shall include all direct and indirect costs, fees and expenses of any type or nature whatsoever, including, without
    limitation, all reasonable attorneys’ fees and costs, retainers, court costs, transcript costs, fees of experts,
    witness fees, travel expenses, fees of private investigators and professional advisors, duplicating costs, printing and
    binding costs, telephone charges, postage, delivery service fees, fax transmission charges, secretarial services and all
    other disbursements, obligations or expenses in connection with prosecuting, defending, preparing to prosecute or defend,
    investigating, being or preparing to be a witness in, settlement or appeal of, or otherwise participating in, a Proceeding
    (as defined below), including reasonable compensation for time spent by Indemnitee for which he or she is not otherwise
    compensated by the Company or any third party.  Expenses also shall include Expenses incurred in connection with any
    appeal resulting from any Proceeding (as defined below), including without limitation the principal, premium, security for,
    and other costs relating to any cost bond, supersedeas bond,
or other appeal bond or its equivalent.  Expenses, however, shall not include amounts paid in settlement by Indemnitee or
the amount of judgments or fines against Indemnitee.

 

    3

     

    

 

		2.10	“Indemnity
    Obligations” shall mean all obligations of the Company to Indemnitee under this Agreement, including, without limitation,
    the Company’s obligations to provide indemnification to Indemnitee and advance Expenses to Indemnitee under this Agreement.

 

		2.11	“Independent
    Counsel” shall mean a law firm or a member of a law firm with significant experience in matters of corporate law
    and neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in
    any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or
    of other indemnitees under similar indemnification agreements); or (ii) any other party to the Proceeding (as defined
    below) giving rise to a claim for indemnification hereunder.  Notwithstanding the foregoing, the term “Independent
    Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing,
    would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s
    rights under this Agreement.

 

		2.12	References to “fines”
    shall include any excise tax assessed on Indemnitee with respect to any employee benefit plan; references to “serving
    at the request of the Company” shall include any service as a director, officer, employee, agent or fiduciary of
    the Company which imposes duties on, or involves services by, such director, officer, employee, agent or fiduciary with respect
    to an employee benefit plan, its participants or beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee
    reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan, Indemnitee
    shall be deemed to have acted in a manner “not opposed to the best interests of the Company” as referred
    to in this Agreement.

 

		2.13	The term “Person”
    shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act as in effect on the date hereof;
    provided, however, that “Person” shall exclude: (i) the Company; (ii) any Subsidiaries (as defined
    below) of the Company; (iii) any employment benefit plan of the Company or of a Subsidiary (as defined below) of the
    Company or of any company or corporation owned, directly or indirectly, by the shareholders of the Company in substantially
    the same proportions as their ownership of share of the Company; and (iv) any trustee or other fiduciary holding securities
    under an employee benefit plan of the Company or of a Subsidiary (as defined below) of the Company or of a company or corporation
    owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of
    share of the Company.

 

		2.14	The term “Proceeding”
    shall include any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute resolution mechanism,
    investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in
    the right of the Company or otherwise and whether of a civil (including intentional or unintentional tort claims), criminal,
    administrative, or investigative or related nature, in which Indemnitee was, is, will or might be involved as a party or otherwise
    by reason of the fact that Indemnitee is or was a director or officer of the Company, by reason of any action (or failure
    to act) taken by him or of any action (or failure to act) on his part while acting as a director or officer of the Company,
    or by reason of the fact that he is or was serving at the request of the Company as a director,

officer,
trustee, general partner, manager, managing member, fiduciary, employee or agent of any other Enterprise, in each case whether
or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement, or
advancement of expenses can be provided under this Agreement.

 

		2.15	The term “Subsidiary,”
    with respect to any Person, shall mean any company, corporation, limited liability company, partnership, joint venture, trust
    or other entity of which a majority of the voting power of the voting equity securities or equity interest is owned, directly
    or indirectly, by that Person.

 

    4

     

    

 

		3	INDEMNITY IN THIRD-PARTY
    PROCEEDINGS

 

To
the fullest extent permitted by applicable law and the Articles, the Company shall indemnify, hold harmless and exonerate Indemnitee
in accordance with the provisions of this Section 3 if Indemnitee was, is, or is threatened to be made, a party to or a participant
(as a witness, deponent or otherwise) in any Proceeding, other than a Proceeding by or in the right of the Company to procure
a judgment in its favor by reason of Indemnitee’s Corporate Status.  Pursuant to this Section 3, Indemnitee
shall be indemnified, held harmless and exonerated against all Expenses, judgments, liabilities, fines, penalties and amounts
paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of
such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably incurred by Indemnitee or on
his behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in
a manner he reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding,
had no reasonable cause to believe that his conduct was unlawful; provided, in no event shall Indemnitee be entitled to be indemnified,
held harmless or advanced any amounts hereunder in respect of any Expenses, judgments, liabilities, fines, penalties and amounts
paid in settlement (if any) that Indemnitee may incur by reason of his or her own actual fraud or intentional misconduct. Indemnitee
shall not be found to have committed actual fraud or intentional misconduct for any purpose of this Agreement unless or until
a court of competent jurisdiction shall have made a finding to that effect.

 

		4	INDEMNITY IN PROCEEDINGS
    BY OR IN THE RIGHT OF THE COMPANY

 

To
the fullest extent permitted by applicable law and the Articles, the Company shall indemnify, hold harmless and exonerate Indemnitee
in accordance with the provisions of this Section 4 if Indemnitee was, is, or is threatened to be made, a party to or a participant
(as a witness, deponent or otherwise) in any Proceeding by or in the right of the Company to procure a judgment in its favor by
reason of Indemnitee’s Corporate Status.  Pursuant to this Section 4, Indemnitee shall be indemnified, held
harmless and exonerated against all Expenses actually and reasonably incurred by him or on his behalf in connection with such
Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably believed to
be in or not opposed to the best interests of the Company.  No indemnification, hold harmless or exoneration for Expenses
shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally
adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the extent that any court in which
the Proceeding was brought or the Cayman Court shall determine upon application that, despite the adjudication of liability but
in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification, to be held
harmless or to exoneration. 

 

		5	INDEMNIFICATION FOR
    EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL

 

Notwithstanding
any other provisions of this Agreement except for Section 27, to the extent that Indemnitee was or is, by reason of Indemnitee’s
Corporate Status, a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense
of any claim, issue or matter therein, in whole or in part, the Company shall, to the fullest extent permitted by applicable law
and the Articles, indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by him
in connection therewith.  If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise,
as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall, to the fullest extent permitted
by applicable law and the Articles, indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably
incurred by him or on his behalf in connection with each successfully resolved claim, issue or matter.  If Indemnitee is
not wholly successful in such Proceeding, the Company also shall, to the fullest extent permitted by applicable law and the Articles,
indemnify, hold harmless and exonerate Indemnitee against all Expenses reasonably incurred in connection with a claim, issue or
matter related to any claim, issue, or matter on which Indemnitee was successful.  For purposes of this Section 5 and
without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice,
shall be deemed to be a successful result as to such claim, issue or matter.

  

    5

     

    

 

		6	INDEMNIFICATION FOR
    EXPENSES OF A WITNESS

 

Notwithstanding
any other provision of this Agreement except for Section 27, to the extent that Indemnitee is, by reason of his Corporate
Status, a witness or deponent in any Proceeding to which Indemnitee is not a party or threatened to be made a party, he shall,
to the fullest extent permitted by applicable law and the Articles, be indemnified, held harmless and exonerated against all Expenses
actually and reasonably incurred by him or on his behalf in connection therewith.

 

		7	ADDITIONAL INDEMNIFICATION,
    HOLD HARMLESS AND EXONERATION RIGHTS

 

		7.1	Notwithstanding any
    limitation in Sections 3, 4, or 5, except for Section 27, the Company shall, to the fullest extent permitted by applicable
    law and the Articles, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to be made
    a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against
    all Expenses, judgments, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges
    paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement)
    actually and reasonably incurred by Indemnitee in connection with the Proceeding.  No indemnification, hold harmless
    or exoneration rights shall be available under this Section 7.1 on account of Indemnitee’s conduct which constitutes
    a breach of Indemnitee’s duty of loyalty to the Company or its shareholders or is an act or omission not in good faith
    or which involves intentional misconduct or a knowing violation of the law.

 

		7.2	Notwithstanding any
    limitation in Sections 3, 4, 5 or 7.1, except for Section 27, the Company shall, to the fullest extent permitted by applicable
    law and the Articles, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to be made
    a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against
    all Expenses, judgments, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges
    paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement)
    actually and reasonably incurred by Indemnitee in connection with the Proceeding.

 

		8	CONTRIBUTION IN THE
    EVENT OF JOINT LIABILITY

 

		8.1	To the fullest extent
    permitted by applicable law and the Articles, if the indemnification, hold harmless and/or exoneration rights provided for
    in this Agreement are unavailable to Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying,
    holding harmless or exonerating Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether
    for judgments, liabilities, fines, penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection
    with any Proceeding without requiring Indemnitee to contribute to such payment, and the Company hereby waives and relinquishes
    any right of contribution it may have at any time against Indemnitee.

 

		8.2	The Company shall not
    enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be if joined
    in such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.

 

		8.3	The Company hereby agrees
    to fully indemnify, hold harmless and exonerate Indemnitee from any claims for contribution which may be brought by officers,
    directors or employees of the Company other than Indemnitee who may be jointly liable with Indemnitee.

 

    6

     

    

 

		9	EXCLUSIONS

 

Notwithstanding
any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnification, advance
expenses, hold harmless or exoneration payment in connection with any claim made against Indemnitee:

 

	 	(a)	for which payment has
    actually been received by or on behalf of Indemnitee under any insurance policy or other indemnity or advancement provision,
    except with respect to any excess beyond the amount actually received under any insurance policy, contract, agreement, other
    indemnity or advancement provision or otherwise;

 

	 	(b)	for an accounting of
    profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning
    of Section 16(b) of the Exchange Act or similar provisions of state statutory law or common law; or

 

	 	(c)	except as otherwise
    provided in Sections 14.5 and 14.6  hereof, prior to a Change in Control, in connection with any Proceeding (or any part
    of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee
    against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding
    (or any part of any Proceeding) prior to its initiation or (ii) the Company provides the indemnification, hold harmless
    or exoneration payment, in its sole discretion, pursuant to the powers vested in the Company under applicable law. Indemnitee
    shall seek payments or advances from the Company only to the extent that such payments or advances are unavailable from any
    insurance policy of the Company covering Indemnitee.

  

		10	ADVANCES OF EXPENSES;
    DEFENSE OF CLAIM

 

		10.1	Notwithstanding any
    provision of this Agreement to the contrary except for Section 27, and to the fullest extent not prohibited by applicable
    law or the Articles, the Company shall pay the Expenses incurred by Indemnitee (or reasonably expected by Indemnitee to be
    incurred by Indemnitee within three months) in connection with any Proceeding within ten (10) days after the receipt
    by the Company of a statement or statements requesting such advances from time to time, prior to the final disposition of
    any Proceeding.  Advances shall, to the fullest extent permitted by applicable law, be unsecured and interest free. Advances
    shall, to the fullest extent permitted by applicable law and the Articles, be made without regard to Indemnitee’s ability
    to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to be indemnified, held harmless or exonerated
    under the other provisions of this Agreement.  Advances shall include any and all reasonable Expenses incurred pursuing
    a Proceeding to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the
    Company to support the advances claimed.  To the fullest extent required by applicable law and the Articles, such payments
    of Expenses in advance of the final disposition of the Proceeding shall be made only upon the Company’s receipt of an
    undertaking, by or on behalf of Indemnitee, to repay the advanced amounts to the extent that it is ultimately determined that
    Indemnitee is not entitled to be indemnified by the Company under the provisions of this Agreement, the Articles, applicable
    law or otherwise. If it shall be determined by a final judgement or other final adjudication that Indemnitee was not
    so entitled to indemnification, any advanced amount shall be returned to the Company (without interest) by the Indemnitee.
    This Section 10.1 shall not apply to any claim made by Indemnitee for which an indemnification, hold harmless or exoneration
    payment is excluded pursuant to Section 9.

 

		10.2	The Company will be
    entitled to participate in the Proceeding at its own expense.

 

		10.3	The Company shall not
    settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, fine, penalty or limitation
    on Indemnitee without Indemnitee’s prior written consent.

 

		11	PROCEDURE FOR NOTIFICATION
    AND APPLICATION FOR INDEMNIFICATION

 

		11.1	Indemnitee agrees to
    notify promptly the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information
    or other document relating to any Proceeding or matter which may be subject to indemnification, hold harmless or exoneration
    rights, or advancement of Expenses covered hereunder.  The failure of Indemnitee to so notify the Company shall not relieve
    the Company of any obligation which it may have to Indemnitee under this Agreement, or otherwise.

 

    7

     

    

 

		11.2	Indemnitee may deliver
    to the Company a written application to indemnify, hold harmless or exonerate Indemnitee in accordance with this Agreement. 
    Such application(s) may be delivered from time to time and at such time(s) as Indemnitee deems appropriate in his
    or her sole discretion.  Following such a written application for indemnification by Indemnitee, Indemnitee’s
    entitlement to indemnification shall be determined according to Section 12.1 of this Agreement.

 

		12	PROCEDURE UPON APPLICATION
    FOR INDEMNIFICATION

 

		12.1	A determination, if
    required by applicable law and the Articles, with respect to Indemnitee’s entitlement to indemnification shall be made
    in the specific case by one of the following methods: (i) if no Change in Control has occurred, (x) by a majority vote of
    the Disinterested Directors, even though less than a quorum of the Board, (y) by a committee of Disinterested Directors, even
    though less than a quorum of the Board, or (z) if there are no Disinterested Directors, or if such Disinterested Directors
    so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or
    (ii) if a Change in Control has occurred, by Independent Counsel in a written opinion to the Board, a copy of which shall
    be delivered to Indemnitee.  The Company will promptly advise Indemnitee in writing with respect to any determination
    that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification
    has been denied.  If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall
    be made within ten (10) days after such determination.  Indemnitee shall reasonably cooperate with the person, persons
    or entity making such determination with respect to Indemnitee’s entitlement to indemnification, including providing
    to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged
    or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. 
    Any costs or Expenses (including reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating
    with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination
    as to Indemnitee’s entitlement to indemnification) and the Company hereby agrees to indemnify and to hold Indemnitee
    harmless therefrom.

 

		12.2	In the event the determination
    of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12.1 hereof, the Independent
    Counsel shall be selected as provided in this Section 12.2.  The Independent Counsel shall be selected by Indemnitee
    (unless Indemnitee shall request that such selection be made by the Board), and Indemnitee shall give written notice to the
    Company advising it of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so
    selected meets the requirements of “Independent Counsel” as defined in Section 2 of this Agreement. 
    If the Independent Counsel is selected by the Board, the Company shall give written notice to Indemnitee advising him of the
    identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements
    of “Independent Counsel” as defined in Section 2 of this Agreement.  In either event, Indemnitee
    or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been
    received, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however,
    that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements
    of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection shall set forth with
    particularity the factual basis of such assertion.  Absent a proper and timely objection, the person so selected shall
    act as Independent Counsel.  If such written objection is so made and substantiated, the Independent Counsel so selected
    may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has
    determined that such objection is without merit.  If, within twenty (20) days after submission by Indemnitee of a written
    request for indemnification pursuant to Section 11.2 hereof, no Independent Counsel shall have been selected and not
    objected to, either the Company or Indemnitee may petition the Cayman Court for resolution of any objection which shall have
    been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as
    Independent Counsel of a person selected by the Cayman Court, and the person with respect to whom all objections are so resolved
    or the person so appointed shall act as Independent Counsel under Section 12.1 hereof.  Upon the due commencement
    of any judicial proceeding or arbitration pursuant to Section 14.1 of this Agreement, Independent Counsel shall
    be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional
    conduct then prevailing).

 

    8

     

    

 

		12.3	The Company agrees to
    pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent Counsel
    against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement
    pursuant hereto.

 

		13	PRESUMPTIONS AND
    EFFECT OF CERTAIN PROCEEDINGS

 

		13.1	In making a determination
    with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination shall presume
    that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification
    in accordance with Section 11.2 of this Agreement, and the Company shall have the burden of proof to overcome that presumption
    in connection with the making by any person, persons or entity of any determination contrary to that presumption.  Neither
    the failure of the Company (including by its Disinterested Directors or Independent Counsel) to have made a determination
    prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because
    Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its Disinterested
    Directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the
    action or create a presumption that Indemnitee has not met the applicable standard of conduct.

 

		13.2	If the person, persons
    or entity empowered or selected under Section 12 of this Agreement to determine whether Indemnitee is entitled to indemnification
    shall not have made a determination within thirty (30) days after receipt by the Company of the request therefor, the requisite
    determination of entitlement to indemnification shall, to the fullest extent permitted by applicable law and the Articles,
    be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee
    of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading,
    in connection with the request for indemnification, or (ii) a final judicial determination that any or all such indemnification
    is expressly prohibited under applicable law; provided, however, that such 30-day period may be extended for a reasonable
    time, not to exceed an additional fifteen (15) days, if the person, persons or entity making the determination with respect
    to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation
    and/or information relating thereto.

 

		13.3	The termination of any
    Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo
    contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect
    the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner
    which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal
    Proceeding, that Indemnitee had reasonable cause to believe that his conduct was unlawful.

 

		13.4	For purposes of any
    determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based
    on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee
    by the directors, managers, managing members, or officers of the Enterprise in the course of their duties, or on the advice
    of legal counsel for the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager,
    or managing member or on information or records given or reports made to the Enterprise, its Board, any committee of the Board
    or any director, trustee, general partner, manager or managing member by an independent certified public accountant or by
    an appraiser or other expert selected by the Enterprise, its Board, any committee of the Board or any director, trustee, general
    partner, manager or managing member.  The provisions of this Section 13.4 shall not be deemed to be exclusive or
    to limit in any way the other circumstances in which Indemnitee may be deemed or found to have met the applicable standard
    of conduct set forth in this Agreement.

 

    9

     

    

 

		13.5	The knowledge and/or
    actions, or failure to act, of any other director, officer, trustee, partner, manager, managing member, fiduciary, agent or
    employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under
    this Agreement.

 

		14	REMEDIES OF INDEMNITEE

 

		14.1	In the event that (i) a
    determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification under
    this Agreement, (ii) advancement of Expenses, to the fullest extent permitted by applicable law and the Articles, is
    not timely made pursuant to Section 10 of this Agreement, (iii) no determination of entitlement to indemnification
    shall have been made pursuant to Section 12.1 of this Agreement within thirty (30) days after receipt by the Company
    of the request for indemnification, (iv) payment of indemnification is not made pursuant to Sections 5, 6, 7 or the last
    sentence of Section 12.1 of this Agreement within ten (10) days after receipt by the Company of a written request
    therefor, (v) a contribution payment is not made in a timely manner pursuant to Section 8 of this Agreement, (vi) payment
    of indemnification pursuant to Section 3 or 4 of this Agreement is not made in accordance with this Agreement within
    ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vii) payment
    to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is not made within ten
    (10) days after receipt by the Company of a written request therefor, Indemnitee shall be entitled to an adjudication
    by the Cayman Court to such indemnification, hold harmless, exoneration, contribution or advancement rights.  Alternatively, Indemnitee,
    at his option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration
    Rules and Mediation Procedures of the American Arbitration Association.  Except as set forth herein, the provisions
    of Cayman Islands law (without regard to its conflict of laws rules) shall apply to any such arbitration.  The Company
    shall not oppose Indemnitee’s right to seek any such adjudication or award in arbitration.

 

		14.2	In the event that a
    determination shall have been made pursuant to Section 12.1 of this Agreement that Indemnitee is not entitled to indemnification,
    any judicial proceeding or arbitration commenced pursuant to this Section 14 shall be conducted in all respects as a
    de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. 
    In any judicial proceeding or arbitration commenced pursuant to this Section 14, Indemnitee shall be presumed to
    be entitled to be indemnified, held harmless, exonerated to receive advances of Expenses under this Agreement and the Company
    shall have the burden of proving Indemnitee is not entitled to be indemnified, held harmless, exonerated and to receive advances
    of Expenses, as the case may be, and the Company may not refer to or introduce into evidence any determination pursuant to
    Section 12.1 of this Agreement adverse to Indemnitee for any purpose.  If Indemnitee commences a judicial proceeding
    or arbitration pursuant to this Section 14, Indemnitee shall not be required to reimburse the Company for any advances
    pursuant to Section 10 until a final determination is made with respect to Indemnitee’s entitlement to indemnification
    (as to which all rights of appeal have been exhausted or lapsed).

 

		14.3	If a determination shall
    have been made pursuant to Section 12.1 of this Agreement that Indemnitee is entitled to indemnification, the Company
    shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 14,
    absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s
    statement not materially misleading, in  

connection
with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.

 

		14.4	The Company shall be
    precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 14 that the procedures
    and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before
    any such arbitrator that the Company is bound by all the provisions of this Agreement.

 

    10

     

    

  

		14.5	The Company shall indemnify
    and hold harmless Indemnitee to the fullest extent permitted by applicable law and the Articles against all Expenses and,
    if requested by Indemnitee, shall (within ten (10) days after the Company’s receipt of such written request) pay
    to Indemnitee, to the fullest extent permitted by applicable law and the Articles, such Expenses which are incurred by Indemnitee
    in connection with any judicial proceeding or arbitration brought by Indemnitee (i) to enforce his rights under, or to
    recover damages for breach of, this Agreement or any other indemnification, hold harmless, exoneration, advancement or contribution
    agreement or provision of the Articles now or hereafter in effect; or (ii) for recovery or advances under any insurance
    policy maintained by any person for the benefit of Indemnitee, regardless of the outcome and whether Indemnitee ultimately
    is determined to be entitled to such indemnification, hold harmless or exoneration right, advancement, contribution or insurance
    recovery, as the case may be (unless such judicial proceeding or arbitration was not brought by Indemnitee in good faith).

 

		14.6	Interest shall be paid
    by the Company to Indemnitee at the legal rate under New York law for amounts which the Company indemnifies, holds harmless
    or exonerates, or is obliged to indemnify, hold harmless or exonerate for the period commencing with the date on which Indemnitee
    requests indemnification, to be held harmless, exonerated, contribution, reimbursement or advancement of any Expenses and
    ending with the date on which such payment is made to Indemnitee by the Company.

 

		15	SECURITY

 

Notwithstanding
anything herein to the contrary except for Section 27, to the extent requested by Indemnitee and approved by the Board, the
Company may at any time and from time to time provide security to Indemnitee for the Company’s obligations hereunder through
an irrevocable bank line of credit, funded trust or other collateral.  Any such security, once provided to Indemnitee, may
not be revoked or released without the prior written consent of Indemnitee.

 

		16	NON-EXCLUSIVITY;
    SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION

 

		16.1	The rights of Indemnitee
    as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled
    under applicable law, the Articles, any agreement, a vote of shareholders or a resolution of directors, or otherwise. 
    No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee
    under this Agreement in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed)
arising out of, or related to, any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment,
alteration or repeal.  To the extent that a change in applicable law, whether by statute or judicial decision, permits greater
indemnification, hold harmless or exoneration rights or advancement of Expenses than would be afforded currently under the Articles
or this Agreement, then this Agreement (without any further action by the parties hereto) shall automatically be deemed to be
amended to require that the Company indemnifies Indemnitee to the fullest extent permitted by law.  No right or remedy herein
conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in
addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. 
The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment
of any other right or remedy.

 

		16.2	The Companies Law (2020
    Revision) of the Cayman Islands and the Articles permit the Company to purchase and maintain insurance or furnish similar
    protection or make other arrangements including, but not limited to, providing a trust fund, letter of credit, or surety bond
    (“Indemnification Arrangements”) on behalf of Indemnitee against any liability asserted against him or
    incurred by or on behalf of him or in such capacity as a director, officer, employee or agent of the Company, or arising out
    of his status as such, whether or not the Company would have the power to indemnify him against such liability under the provisions
    of this Agreement or under the Companies Law (2020 Revision) of the Cayman Islands, as it may then be in effect.  The
    purchase, establishment, and maintenance of any such Indemnification Arrangement shall not in any way limit or affect the
    rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided herein, and the execution
    and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights and obligations
    of the Company or the other party or parties thereto under any such Indemnification Arrangement.

 

    11

     

    

 

		16.3	To the extent that the
    Company maintains an insurance policy or policies providing liability insurance for directors, officers, trustees, partners,
    managers, managing members, fiduciaries, employees, or agents of the Company or of any other Enterprise which such person
    serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with its or
    their terms to the maximum extent of the coverage available for any such director, officer, trustee, partner, manager, managing
    member, fiduciary, employee or agent under such policy or policies.  If, at the time the Company receives notice from
    any source of a Proceeding as to which Indemnitee is a party or a participant (as a witness, deponent or otherwise), the Company
    has director and officer liability insurance in effect, the Company shall give prompt notice of such Proceeding to the insurers
    in accordance with the procedures set forth in the respective policies.  The Company shall thereafter take all necessary
    or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding
    in accordance with the terms of such policies.

 

		16.4	In the event of any
    payment under this Agreement, the Company, to the fullest extent permitted by applicable law and the Articles, shall be subrogated
    to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take
    all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company
    to bring suit to enforce such rights. No such payment by the Company shall be deemed to relive any insurer of its obligations.

 

		16.5	The Company’s
    obligation to indemnify, hold harmless, exonerate or advance Expenses hereunder to Indemnitee who is or was serving at the
    request of the Company as a director, officer, trustee, partner, manager, managing member, fiduciary, employee or agent of
    any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification, hold harmless or
    exoneration payments or advancement of expenses from such Enterprise.  Notwithstanding any other provision of this Agreement
    to the contrary except for Section 27, (i) Indemnitee shall have no obligation to reduce, offset, allocate, pursue
    or apportion any indemnification, hold harmless, exoneration, advancement, contribution or insurance coverage among multiple
    parties possessing such duties to Indemnitee prior to the Company’s satisfaction and performance of all its obligations
    under this Agreement, and (ii) the Company shall perform fully its obligations under this Agreement without regard to
    whether Indemnitee holds, may pursue or has pursued any indemnification, advancement, hold harmless, exoneration, contribution
    or insurance coverage rights against any person or entity other than the Company.

 

		16.6	The Company hereby acknowledges
    that Indemnitee may have certain rights to indemnification, advancement of Expenses and/or insurance provided by one or more
    Persons with whom or which Indemnitee may be associated. The Company hereby acknowledges and agrees that (i) the Company shall
    be the indemnitor of first resort with respect to any Proceeding, Expense, liability or matter that is the subject of the
    Indemnity Obligations, (ii) the Company shall be primarily liable for all Indemnity Obligations and any indemnification afforded
    to Indemnitee in respect of any Proceeding, Expense, liability or matter that is the subject of Indemnity Obligations, whether
    created by law, organizational or constituent documents, contract (including, without limitation, this Agreement) or otherwise,
    (iii) any obligation of any other Persons with whom or which Indemnitee may be associated to indemnify Indemnitee and/or advance
    Expenses to Indemnitee in respect of any proceeding shall be secondary to the obligations of the Company hereunder, (iv) the
    Company shall be required to indemnify Indemnitee and advance Expenses to Indemnitee hereunder to the fullest extent provided
    herein without regard to any rights Indemnitee may have against any other Person with whom or which Indemnitee may be associated
    or insurer of any such Person and (v) the Company irrevocably waives, relinquishes and releases any other Person with whom
    or which Indemnitee may be associated from any claim of contribution, subrogation or any other recovery of any kind in respect
    of amounts paid by the Company hereunder. In the event that any other Person with whom or which Indemnitee may be associated
    or their insurers advances or extinguishes any liability or loss which is the subject of any Indemnity Obligation owed by
    the Company or payable under any insurance policy provided under this Agreement, the payor shall have a right of subrogation
    against the Company or its insurer or insurers for all amounts so paid which would otherwise be payable by the Company or
    its insurer or insurers under this Agreement. In no event will payment of an Indemnity Obligation of the Company under this
    Agreement by any other Person with whom or which Indemnitee may be associated or their insurers, affect the obligations of
    the Company hereunder or shift primary liability for any Indemnity Obligation to any other Person with whom or which Indemnitee
    may be associated. Any indemnification and/or insurance or advancement of Expenses provided by any other Person with whom
    or which Indemnitee may be associated, with respect to any liability arising as a result of Indemnitee’s Corporate Status
    or capacity as an officer or director of any Person, is specifically in excess of any Indemnity Obligation of the Company
    or valid and any collectible insurance (including, without limitation, any malpractice insurance or professional errors and
    omissions insurance) provided by the Company under this Agreement, and any obligation to provide indemnification and/or insurance
    or advance Expenses provided by any other Person with whom or which Indemnitee may be associated shall be reduced by any amount
    that Indemnitee collects from the Company as an indemnification payment or advancement of Expenses pursuant to this Agreement.

 

    12

     

    

 

		17	DURATION OF AGREEMENT

 

All
agreements and obligations of the Company contained herein shall continue during the period Indemnitee serves as a director or
officer of the Company or as a director, officer, trustee, partner, manager, managing member, fiduciary, employee or agent of
any other company, corporation, partnership, joint venture, trust, employee benefit plan or other Enterprise which Indemnitee
serves at the request of the Company and shall continue thereafter so long as Indemnitee shall be subject to any possible Proceeding
(including any rights of appeal thereto and any Proceeding commenced by Indemnitee pursuant to Section 14 of this Agreement)
by reason of his Corporate Status, whether or not he is acting in any such capacity at the time any liability or expense is incurred
for which indemnification or advancement can be provided under this Agreement.

 

		18	SEVERABILITY

 

If
any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever:
(a) the validity, legality and enforceability of the remaining provisions of this Agreement (including, without limitation,
each portion of any Section, paragraph or sentence of this  Agreement containing any such provision held to be invalid, illegal
or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and
shall remain enforceable to the fullest extent permitted by applicable law (and the Articles); (b) such provision or provisions
shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of
the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation,
each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal
or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent
manifested thereby.

 

		19	ENFORCEMENT AND BINDING
    EFFECT

 

		19.1	The Company expressly
    confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce
    Indemnitee to serve as a director, officer or key employee of the Company, and the Company acknowledges that Indemnitee is
    relying upon this Agreement in serving as a director, officer or key employee of the Company.

 

		19.2	Without limiting any
    of the rights of Indemnitee under the Articles as they may be amended from time to time, this Agreement constitutes the entire
    agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings,
    oral, written and implied, between the parties hereto with respect to the subject matter hereof.

 

		19.3	The indemnification,
    hold harmless, exoneration and advancement of expenses rights provided by or granted pursuant to this Agreement shall be binding
    upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect
    successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the
    Company), shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or
    a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent of any other Enterprise
    at the Company’s request, and shall inure to the benefit of Indemnitee and his or her spouse, assigns, heirs, devisees,
    executors and administrators and other legal representatives.

 

    13

     

    

 

		19.4	The Company shall require
    and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially
    all or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory
    to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the
    Company would be required to perform if no such succession had taken place.

 

		19.5	The Company and Indemnitee
    agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and
    difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm.  Accordingly, the parties
    hereto agree that Indemnitee may, to the fullest extent permitted by applicable law and the Articles, enforce this Agreement
    by seeking, among other things, injunctive relief and/or specific performance hereof, without any necessity of showing actual
    damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be
    precluded from seeking or obtaining any other relief to which he may be entitled.  The Company and Indemnitee further
    agree that Indemnitee shall to the fullest extent permitted by applicable law (and the Articles) be entitled to such specific
    performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions,
    without the necessity of posting bonds or other undertaking in connection therewith.  The Company acknowledges that in
    the absence of a waiver, a bond or undertaking may be required of Indemnitee by a Court of competent jurisdiction and the
    Company hereby waives any such requirement of such a bond or undertaking to the fullest extent permitted by applicable law
    and the Articles.

 

		20	MODIFICATION AND
    WAIVER

 

No
supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the Company and Indemnitee. 
No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this
Agreement nor shall any waiver constitute a continuing waiver.

 

		21	NOTICES

 

All
notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been
duly given (i) if delivered by hand and receipted for by the party to whom said notice or other communication shall have
been directed, or (ii) mailed by certified or registered mail with postage prepaid, on the third (3rd) business day after
the date on which it is so mailed:

 

	 	(a)	If to Indemnitee, at
    the address indicated on the signature page of this Agreement or such other address as Indemnitee shall provide in writing
    to the Company.

 

	 	(b)	If to the Company, to:

 

Bridgetown
Holdings Limited

38/F
Champion Tower

3
Garden Road, Central

Hong
Kong

Attn: Daniel Wong

 

With
a copy, which shall not constitute notice, to:

 

Ellenoff
Grossman & Schole LLP

1345
Avenue of the Americas, 11th Floor

New
York, New York 10105

Attn:
Stuart Neuhauser, Esq. 

 

or
to any other address as may have been furnished to Indemnitee in writing by the Company.

 

    14

     

    

 

		22	APPLICABLE LAW AND
    CONSENT TO JURISDICTION

 

This
Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws
of the State of New York. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14.1 of this
Agreement, to the fullest extent permitted by law the Company and Indemnitee hereby irrevocably and unconditionally: (a) agree
that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Courts of the State
of New York and not in any other state or federal court in the United States of America or any court in any other country; (b) consent
to submit to the exclusive jurisdiction of the Courts of the State of New York for purposes of any action or proceeding arising
out of or in connection with this Agreement; (c) waive any objection to the laying of venue of any such action or proceeding
in the Courts of the State of New York; and (d) waive, and agree not to plead or to make, any claim that any such action
or proceeding brought in the Courts of the State of New York has been brought in an improper or inconvenient forum, or is subject
(in whole or in part) to a jury trial. To the fullest extent permitted by law, the parties hereby agree that the mailing of process
and other papers in connection with any such action or proceeding in the manner provided by Section 21 or such other manner as
may be permitted by law, shall be valid and sufficient service thereof.

 

		23	IDENTICAL COUNTERPARTS

 

This
Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all
of which together shall constitute one and the same Agreement.  Only one such counterpart signed by the party against whom
enforceability is sought needs to be produced to evidence the existence of this Agreement.

 

		24	MISCELLANEOUS

 

Use
of the masculine pronoun shall be deemed to include usage of the feminine pronoun where appropriate.  The headings of the
paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or
to affect the construction thereof.

 

		25	PERIOD OF LIMITATIONS

 

No
legal action shall be brought and no cause of action shall be asserted by or in the right of the Company against Indemnitee, Indemnitee’s
spouse, heirs, executors or personal or legal representatives after the expiration of two years from the date of accrual of such
cause of action, and any claim or cause of action of the Company shall be extinguished and deemed released unless asserted by
the timely filing of a legal action within such two-year period; provided, however, that if any shorter period of limitations
is otherwise applicable to any such cause of action such shorter period shall govern.

 

		26	ADDITIONAL ACTS

 

If
for the validation of any of the provisions in this Agreement any act, resolution, approval or other procedure is required, to
the fullest extent permitted by law, the Company undertakes to cause such act, resolution, approval or other procedure to be affected
or adopted in a manner that will enable the Company to fulfil its obligations under this Agreement.

 

		27	WAIVER OF CLAIMS
    TO TRUST ACCOUNT

 

Indemnitee
hereby agrees that it does not have any right, title, interest or claim of any kind (each, a “Claim”) in or
to any monies in the trust account established in connection with the Company’s initial public offering for the benefit
of the Company and holders of shares issued in such offering, and hereby waives any Claim it may have in the future as a result
of, or arising out of, any services provided to the Company and will not seek recourse against such trust account for any reason
whatsoever. Accordingly, Indemnitee acknowledges and agrees that any indemnification provided hereto will only be able to be satisfied
by the Company if (i) the Company has sufficient funds outside of the Trust Account to satisfy its obligations hereunder or (ii)
the Company consummated a Business Combination.

 

    15

     

    

 

		28.	MAINTENANCE OF INSURANCE

 

The
Company shall use commercially reasonable efforts to obtain and maintain in effect during the entire period for which the Company
is obligated to indemnify the Indemnitee under this Agreement, one or more policies of insurance with reputable insurance companies
to provide the officers/directors of the Company with coverage for losses from wrongful acts and omissions and to ensure the Company’s
performance of its indemnification obligations under this Agreement. The Indemnitee shall be covered by such policy or policies
in accordance with its or their terms to the maximum extent of the coverage available for any such director or officer under such
policy or policies. In all such insurance policies, the Indemnitee shall be named as an insured in such a manner as to provide
the Indemnitee with the same rights and benefits as are accorded to the most favorably insured of the Company’s directors
and officers.

 

		29.	INTERPRETATION

 

In
this Agreement:

 

	 	(a)	words importing the
    singular number include the plural number and vice versa; words importing the masculine gender include the feminine gender;

 

	 	(b)	“written”
    and “in writing” include all modes of representing or reproducing words in visible form, including in the form
    of an Electronic Record;

 

	 	(c)	“shall”
    shall be construed as imperative and “may” shall be construed as permissive;

 

	 	(d)	references to provisions
    of any law or regulation shall be construed as references to those provisions as amended, modified, re-enacted or replaced;

 

	 	(e)	any phrase introduced
    by the terms “including”, “include”, “in particular” or any similar expression shall be
    construed as illustrative and shall not limit the sense of the words preceding those terms;

 

	 	(f)	the term “and/or”
    is used herein to mean both “and” as well as “or. ” The use of “and/or” in certain contexts
    in no respects qualifies or modifies the use of the terms “and" or “or" in others. The term "or"
    shall not be interpreted to be exclusive and the term “and” shall not be interpreted to require the conjunctive
    (in each case, unless the context otherwise requires);

 

	 	(g)	headings are inserted
    for reference only and shall be ignored in construing this Agreement;

 

	 	(h)	any requirements as
    to delivery under this Agreement include delivery in the form of an electronic record (as defined in the Electronic Transactions
    Law (2003));

 

	 	(i)	any requirements as
    to execution or signature under this Agreement including the execution of this Agreement itself can be satisfied in the form
    of an electronic signature (as defined in the Electronic Transactions Law (2003 Revision));

 

	 	(j)	sections 8 and 19(3)
    of the Electronic Transactions Law (2003 Revision) shall not apply.

 

[SIGNATURE
PAGE FOLLOWS]

 

    16

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed on the day and year first above written.

 

	 	Bridgetown
    Holdings Limited
	 	 
	 	By:	 
	 	 	Name:	Daniel
    Wong
	 	 	Title:	Chief Executive Officer
    and Chief Financial Officer
	 	 	 
	 	 	INDEMNITEE
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	 
	 	 	 
	 	 	Address:
	 	 	 
	 	 	 

 

[Signature
Page to Indemnity Agreement]

 

17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]